As we head into September, the final month of the third quarter, it's time to take a closer look at the biotech and pharmaceutical companies with drug candidates awaiting FDA decisions.
September is also a month of several significant observances, including World Alzheimer's Month, Blood Cancer Awareness Month, and Childhood Cancer Awareness Month, among others.
So far this year (January through August), the FDA has approved 26 novel drugs - slightly trailing the 29 approvals recorded during the same period last year.
Now, let's explore the drug candidates currently under FDA review, with potential approvals on the horizon this September.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.